Início/Ações/SABSW

SABSW

USD

SAB Biotherapeutics Inc. Warrant

$0.028-0.020 (-41.300%)

Preço em tempo real

Healthcare

Biotecnologia

Estados Unidos

Gráfico de preços

Loading Chart...

Métricas-chave

Métricas de mercado

Fundamentos da empresa

Estatísticas de negociação

Métricas de mercado

Abertura

$0.048

Máximo

$0.039

Mínimo

$0.028

Volume

0.01M

Fundamentos da empresa

Setor

Biotecnologia

País

United States

Estatísticas de negociação

Bolsa de valores

NCM

Moeda

USD

Faixa de 52 semanas

Mínimo $0.028Atual $0.028Máximo $0.0391

Notícias relacionadas

4/11/2025 · 13:30

GlobeNewswire

SAB BIO to Present Data at the International Society for Pediatric and Adolescent Diabetes Annual Conference Showcasing Progress in the Development of SAB-142

MIAMI, Nov. 04, 2025 (GLOBE NEWSWIRE) -- SAb Biotherapeutics, Inc. (NASDAQ:SABS), a clinical-stage biopharmaceutical company developing human anti-thymocyte immunoglobulin (hATG) for type 1 diabetes (T1D) and other

Ver mais

4/11/2025 · 13:00

GlobeNewswire

SAB BIO to Participate in Upcoming Investor Conferences

MIAMI, Nov. 04, 2025 (GLOBE NEWSWIRE) -- SAb Biotherapeutics, Inc. (Nasdaq: SABS), a clinical-stage biopharmaceutical company developing human anti-thymocyte immunoglobulin (hATG) for autoimmune diseases, including its

Ver mais